보티옥세틴 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "보티옥세틴" in Korean language version.

refsWebsite

Global rank Korean rank

6doi.org

2^nd place

3^rd place

5nih.gov

4^th place

2web.archive.org

1^st place

1worldcat.org

5^th place

11^th place

1tga.gov.au

3,984^th place

1,245^th place

doi.org

dx.doi.org

Connolly, KR; Thase, ME (2016). “Vortioxetine: a New Treatment for Major Depressive Disorder.”. 《Expert opinion on pharmacotherapy》 17 (3): 421–31. doi:10.1517/14656566.2016.1133588. PMID 26679430. The authors suggest that vortioxetine is currently a good second-line antidepressant option and shows promise, pending additional long-term data, to become a first-line antidepressant option.
Köhler S, Cierpinsky K, Kronenberg G, Adli M. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants. J Psychopharmacol. 2016 Jan;30(1):13-22. doi 10.1177/0269881115609072 PMID 26464458
Kelliny M, Croarkin PE, Moore KM, Bobo WV. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Ther Clin Risk Manag. 2015 Aug 12;11:1193-212. doi 10.2147/TCRM.S55313 PMID 26316764 Free full text 보관됨 2018-04-29 - 웨이백 머신
Sanchez, Connie; Asin, Karen E.; Artigas, Francesc (2015년 1월). “Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data”. 《Pharmacology & Therapeutics》 145: 43–57. doi:10.1016/j.pharmthera.2014.07.001. ISSN 0163-7258.
Bang-Andersen B, Ruhland T, Jørgensen M, 외. (May 2011). “Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder”. 《Journal of Medicinal Chemistry》 54 (9): 3206–21. doi:10.1021/jm101459g. PMID 21486038.

doi.org

Sanchez, Connie; Asin, Karen E.; Artigas, Francesc (2015년 1월). “Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data”. 《Pharmacology & Therapeutics》 145: 43–57. doi:10.1016/j.pharmthera.2014.07.001. ISSN 0163-7258.

nih.gov

ncbi.nlm.nih.gov

Connolly, KR; Thase, ME (2016). “Vortioxetine: a New Treatment for Major Depressive Disorder.”. 《Expert opinion on pharmacotherapy》 17 (3): 421–31. doi:10.1517/14656566.2016.1133588. PMID 26679430. The authors suggest that vortioxetine is currently a good second-line antidepressant option and shows promise, pending additional long-term data, to become a first-line antidepressant option.
Kelliny M, Croarkin PE, Moore KM, Bobo WV. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Ther Clin Risk Manag. 2015 Aug 12;11:1193-212. doi 10.2147/TCRM.S55313 PMID 26316764 Free full text 보관됨 2018-04-29 - 웨이백 머신
Bang-Andersen B, Ruhland T, Jørgensen M, 외. (May 2011). “Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder”. 《Journal of Medicinal Chemistry》 54 (9): 3206–21. doi:10.1021/jm101459g. PMID 21486038.

pubmed.ncbi.nlm.nih.gov

Köhler S, Cierpinsky K, Kronenberg G, Adli M. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants. J Psychopharmacol. 2016 Jan;30(1):13-22. doi 10.1177/0269881115609072 PMID 26464458
Kelliny M, Croarkin PE, Moore KM, Bobo WV. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Ther Clin Risk Manag. 2015 Aug 12;11:1193-212. doi 10.2147/TCRM.S55313 PMID 26316764 Free full text 보관됨 2018-04-29 - 웨이백 머신

tga.gov.au

“Australian Public Assessment Report for vortioxetine hydrobromide” (PDF). 11쪽. 2017년 8월 1일에 원본 문서 (PDF)에서 보존된 문서. 2018년 5월 5일에 확인함.

web.archive.org

Kelliny M, Croarkin PE, Moore KM, Bobo WV. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Ther Clin Risk Manag. 2015 Aug 12;11:1193-212. doi 10.2147/TCRM.S55313 PMID 26316764 Free full text 보관됨 2018-04-29 - 웨이백 머신
“Australian Public Assessment Report for vortioxetine hydrobromide” (PDF). 11쪽. 2017년 8월 1일에 원본 문서 (PDF)에서 보존된 문서. 2018년 5월 5일에 확인함.

worldcat.org

Sanchez, Connie; Asin, Karen E.; Artigas, Francesc (2015년 1월). “Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data”. 《Pharmacology & Therapeutics》 145: 43–57. doi:10.1016/j.pharmthera.2014.07.001. ISSN 0163-7258.